Stock Rich List
Nasdaq: KYMR

Kymera Therapeutics insiders

The officers, directors and 10% owners of Kymera Therapeutics, Inc. who hold the most stock, valued at the live KYMR price.

$119.39
KYMR today −$1.7M (−1.44%)
Market closed. Prices as of Nov 19, 4:04 PM ET
Ranked insiders
13
Their KYMR stock
$3.01B
Market value
$10.19B
Held by ranked insiders
29.5%

Insiders by value of KYMR holdings

SEC ownership page
#InsiderRoleSharesValueOf companyOverall rank
1Atlas Venture Fund X, L.P.10% owner6,586,996$786M7.72%Corporate
2Atlas Venture Associates Opportunity I, L.P.10% owner6,366,980$760M7.46%Corporate
3Atlas Venture Opportunity Fund I, L.P.10% owner5,858,262$699M6.86%Corporate
4Atlas Venture Associates Opportunity I, LLC10% owner4,676,075$558M5.48%Corporate
5Nello MainolfiChief Executive Officer666,568$79.6M0.78%1805th
6Biotechnology Value Trading Fund OS LPDirector484,057$57.8M0.57%Corporate
7Bruce N. JacobsChief Financial Officer244,883$29.2M0.29%3859th
8Jared GollobChief Medical Officer117,134$14.0M0.14%6806th
9Ellen ChiniaraChief Legal Officer80,085$9.6M<0.1%9086th
10Brian AdamsChief Legal Officer50,254$6.0M<0.1%7698th
11Noah GoodmanChief Business Officer47,179$5.6M<0.1%13327th
12Jeremy G. ChadwickChief Operating Officer44,018$5.3M<0.1%13974th
13Pamela EspositoDirector1,000$119K<0.1%14098th

Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for Kymera Therapeutics; see each profile for the filing.